Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1RAs have shown modest beneficial effects on fasting plasma lipid levels in patients with T2DM [36, 37].”
From Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms (2022) · cites this paper as [37]
Citations
Cites
Still being checked.
Cited by
Nauck, M. A., Meier, J. J., Cavender, M. A., Abd El Aziz, M., & Drucker, D. J. (2017) · Circulation · doi:10.1161/circulationaha.117.028136 · Cited by 582
Frias, J. P., Bastyr, E. J., Vignati, L., Tschöp, M. H., Schmitt, C., Owen, K., Christensen, R. H., & DiMarchi, R. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.011 · Cited by 321
“Lowering in fasting lipids is not consistently seen for GLP-1RAs, with the effect varying by trial length and size (Davies et al., 2015; Hermansen et al., 2013; Nauck et al., 2013; Plutzky et al., 2009).”
BackgroundRizzo, M., Rizvi, A. A., Patti, A. M., Nikolic, D., Giglio, R. V., Castellino, G., Li Volti, G., Caprio, M., Montalto, G., Provenzano, V., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0480-8 · Cited by 135
Helmstädter, J., Keppeler, K., Küster, L., Münzel, T., Daiber, A., & Steven, S. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15462 · Cited by 99
Vergès, B., Aboyans, V., Angoulvant, D., Boutouyrie, P., Cariou, B., Hyafil, F., Mohammedi, K., & Amarenco, P. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01686-3 · Cited by 72
“GLP-1RAs have shown modest beneficial effects on fasting plasma lipid levels in patients with T2DM [36, 37].”
Background
Metadata
- Authors
- Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R.
- Affiliations
- Brigham and Women's Hospital (US)
- Baylor College of Medicine (US)
- Novo Nordisk (Denmark) (DK)
- Imperial College London (GB)
- Venue
- Canadian Journal of Diabetes
- Publisher
- Elsevier BV
- Published
- 2009
- Volume
- 33
- Issue
- 3
- Pages
- 209-210
- ISSN
- 1499-2671 (ISSN-L)
- OpenAlex
- W2059523942
- Cited by
- 33
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 7 · 2016: 2
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Canadian Journal of Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- liraglutide, type 2 diabetes, GLP-1 receptor agonists, lipid profile, cardiovascular risk markers, HbA1c, weight loss, systolic blood pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. https://app.cochat.ai/papers/10.1016/s1499-2671(09)33072-5
- The paper
- Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R. (2009). Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Canadian Journal of Diabetes. https://doi.org/10.1016/s1499-2671(09)33072-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.